⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Brightonix Imaging and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Brightonix Imaging
↗Seoul, South Korea
Brightonix Imaging is a medical technology company based in Seoul, South Korea, specializing in the development of advanced nuclear imaging systems, including high-performance Positron Emission Tomography (PET) scanners. The company focuses on innovative hardware design and AI-based software solutions to improve diagnostic accuracy, patient experience, and workflow efficiency in clinical and preclinical settings.
Their flagship product, the PHAROS PET scanner, features multi-functional capabilities such as adjustable configurations for brain, breast, and extremity imaging. The company is actively expanding its global footprint, recently securing FDA clearance for its clinical imaging technology.
CLASSIFICATION
Company Type:MedTech
Therapeutic Areas:
Industry:Medical Devices
Sub-Industry:Medical Imaging / Diagnostic Equipment
SIZE & FINANCIALS
Employees:51-200
Founded:2016
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Medical Device)
Modalities:PET Imaging, AI-based Diagnostics
Active Trials:0
Trial Phases:-
FDA Approvals:1
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:510K FDA Inc. (Regulatory Consulting)
COMPETITION
Position:Emerging
Competitors:GE Healthcare, Siemens Healthineers, Philips Healthcare
LEADERSHIP
Key Executives:
Jae sung Lee - CEO
LINKS
Website:brtnx.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Brightonix Imaging. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.